Tonix Pharmaceuticals
TNXP
#9180
Rank
HK$1.23 B
Marketcap
HK$77.47
Share price
-6.97%
Change (1 day)
-77.93%
Change (1 year)

Revenue for Tonix Pharmaceuticals (TNXP)

Revenue in 2026 (TTM): HK$0.13 Billion

According to Tonix Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is HK$0.13 Billion. In 2025 the company made a revenue of HK$0.10 Billion an increase over the revenue in the year 2024 that were of HK$78.36 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Tonix Pharmaceuticals from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) HK$0.13 B34.47%
2025 HK$0.10 B30.14%
2024 HK$78.36 M29.17%
2023 HK$60.66 M
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Aerie Pharmaceuticals
AERI
HK$1.67 B 1,118.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
HK$2.01 B 1,367.03%๐Ÿ‡บ๐Ÿ‡ธ USA